Literature DB >> 1270076

The relation of sex, age, smoking status, birth rank and parental ages to pseudocholinesterase activity and phenotypes in a sample of Australian Caucasian adults.

D N Propert, C J Brackenridge.   

Abstract

The frequencies of the pseudocholinesterase alleles E1u, E1a and E1f have been determined in a random sample of Australian residents. The frequency of E1a is the highest yet reported in a large caucasian sample. The considerable variation in E1f frequencies in previously reported samples is discussed in terms of possible sources of error in fluoride number determinations. Enzyme activity was found to increase with age in adulthood and was higher in males than in females. It was also positively correlated with dibucaine number in type U subjects. These observations are in conflict with those reported in previous investigations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270076     DOI: 10.1007/BF00291501

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  THE CLINICAL STABILITY OF SERUM CHOLINESTERASE ACTIVITY.

Authors:  H J WETSTONE; R V LAMOTTA
Journal:  Clin Chem       Date:  1965-06       Impact factor: 8.327

2.  PROCEDURE FOR DETECTING A TYPICAL SERUM CHOLINESTERASE USING O-NITROPHENYLBUTYRATE AS SUBSTRATE.

Authors:  R B MCCOMB; R V LAMOTTA; H J WETSTONE
Journal:  Clin Chem       Date:  1965-06       Impact factor: 8.327

3.  Frequency of atypical pseudocholinesterase in British and Mediterranean populations.

Authors:  C KATTAMIS; L ZANNOS-MARIOLEA; A P FRANCO; J LIDDELL; H LEHMANN; D DAVIES
Journal:  Nature       Date:  1962-11-10       Impact factor: 49.962

4.  Study of cholinesterase activity in nervous and mental disorders.

Authors:  C M PLUM
Journal:  Clin Chem       Date:  1960-08       Impact factor: 8.327

5.  On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.

Authors:  W KALOW; N STARON
Journal:  Can J Biochem Physiol       Date:  1957-12

6.  The pseudocholinesterase variants. A family segregating for two homozygotes with the fluoride resistant gene.

Authors:  M Whittaker; M Berry
Journal:  Hum Hered       Date:  1972       Impact factor: 0.444

7.  High frequency of atypical pseudocholinesterase gene among Iraqi and Iranian Jews.

Authors:  A Szeinberg; S Pipano; M Assa; J H Medalie; H N Neufeld
Journal:  Clin Genet       Date:  1972       Impact factor: 4.438

8.  A study of the pseudocholinesterase polymorphism among a panjabi population.

Authors:  S Singh; M K Amma; K N Sareen; H W Goedde
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

9.  Screening of 563 students for cholinesterase variants.

Authors:  C E Becker
Journal:  Clin Chem       Date:  1972-01       Impact factor: 8.327

10.  Pseudocholinesterase-variants in Thailand and Japan.

Authors:  K Altland; F Epple; H W Goedde
Journal:  Humangenetik       Date:  1967
View more
  4 in total

1.  Laboratory and field microassay of cholinesterases in whole blood, plasma, and erythrocytes.

Authors:  W G Brogdon
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

2.  The relation of sex, smoking status, birth rank, and parental age to beta2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults.

Authors:  D N Propert
Journal:  Hum Genet       Date:  1978-09-19       Impact factor: 4.132

3.  Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers.

Authors:  S E Lukas; M Sholar; L H Lundahl; X Lamas; E Kouri; J D Wines; L Kragie; J H Mendelson
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

4.  Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.

Authors:  Yutaka Aoki; Kathy J Helzlsouer; Paul T Strickland
Journal:  Int J Environ Res Public Health       Date:  2014-01-27       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.